Agreement Between Labial Biopsy and the OMERACT Grey-scale Ultrasound Scoring System for Salivary Glands in a Single-center Cohort of Patients with Suspected Sjögren’s Syndrome

Abstract

Background/Purpose:
Ultrasound is a promising non-invasive tool in the evaluation of the salivary glands for parenchymal changes related to Sjögrens Syndrome (SS). The OMERACT Ultrasound Grey-scale (GS) Scoring System for SS has been shown to have good sensitivity and excellent specificity for fulfilling the SS classification criteria, when a GS ≥2 in at least 1 gland was considered indicative of SS (1), however others have suggested pathology in at least 2 glands is required (2). Systematic use of ultrasound might reduce the need for labial biopsies if US findings are in agreement with biopsies.
OriginalsprogEngelsk
Publikationsdato2022
StatusUdgivet - 2022
BegivenhedEULAR 2022 - Copenhagen
Varighed: 1 jun. 20224 jun. 2022

Konference

KonferenceEULAR 2022
ByCopenhagen
Periode01/06/202204/06/2022

Fingeraftryk

Dyk ned i forskningsemnerne om 'Agreement Between Labial Biopsy and the OMERACT Grey-scale Ultrasound Scoring System for Salivary Glands in a Single-center Cohort of Patients with Suspected Sjögren’s Syndrome'. Sammen danner de et unikt fingeraftryk.

Citationsformater